628 related articles for article (PubMed ID: 19414634)
1. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
Gutiérrez OM; Januzzi JL; Isakova T; Laliberte K; Smith K; Collerone G; Sarwar A; Hoffmann U; Coglianese E; Christenson R; Wang TJ; deFilippi C; Wolf M
Circulation; 2009 May; 119(19):2545-52. PubMed ID: 19414634
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
[TBL] [Abstract][Full Text] [Related]
4. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
[TBL] [Abstract][Full Text] [Related]
5. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
Seiler S; Cremers B; Rebling NM; Hornof F; Jeken J; Kersting S; Steimle C; Ege P; Fehrenz M; Rogacev KS; Scheller B; Böhm M; Fliser D; Heine GH
Eur Heart J; 2011 Nov; 32(21):2688-96. PubMed ID: 21733911
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
[TBL] [Abstract][Full Text] [Related]
9. Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese.
Lin Z; Zhou Z; Liu Y; Gong Q; Yan X; Xiao J; Wang X; Lin S; Feng W; Li X
PLoS One; 2011 Apr; 6(4):e18398. PubMed ID: 21525989
[TBL] [Abstract][Full Text] [Related]
10. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients.
Garland JS; Holden RM; Ross R; Adams MA; Nolan RL; Hopman WM; Morton AR
J Diabetes Complications; 2014; 28(1):61-5. PubMed ID: 24125760
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).
Mathew JS; Sachs MC; Katz R; Patton KK; Heckbert SR; Hoofnagle AN; Alonso A; Chonchol M; Deo R; Ix JH; Siscovick DS; Kestenbaum B; de Boer IH
Circulation; 2014 Jul; 130(4):298-307. PubMed ID: 24920722
[TBL] [Abstract][Full Text] [Related]
13. Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease.
Unsal A; Kose Budak S; Koc Y; Basturk T; Sakaci T; Ahbap E; Sinangil A
Kidney Blood Press Res; 2012; 36(1):55-64. PubMed ID: 22854270
[TBL] [Abstract][Full Text] [Related]
14. Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.
Kerr JD; Holden RM; Morton AR; Nolan RL; Hopman WM; Pruss CM; Garland JS
BMC Nephrol; 2013 Jan; 14():26. PubMed ID: 23351146
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-23 and cardiac structure and function.
Agarwal I; Ide N; Ix JH; Kestenbaum B; Lanske B; Schiller NB; Whooley MA; Mukamal KJ
J Am Heart Assoc; 2014 Feb; 3(1):e000584. PubMed ID: 24525546
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
Manghat P; Fraser WD; Wierzbicki AS; Fogelman I; Goldsmith DJ; Hampson G
Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
[TBL] [Abstract][Full Text] [Related]
19. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.
Jovanovich A; Ix JH; Gottdiener J; McFann K; Katz R; Kestenbaum B; de Boer IH; Sarnak M; Shlipak MG; Mukamal KJ; Siscovick D; Chonchol M
Atherosclerosis; 2013 Nov; 231(1):114-9. PubMed ID: 24125420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
